Eintrag weiter verarbeiten
Activated protein C to heal pressure ulcers
Gespeichert in:
| Zeitschriftentitel: | International Wound Journal |
|---|---|
| Personen und Körperschaften: | , , , , , , |
| In: | International Wound Journal, 13, 2016, 5, S. 986-991 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Wijewardena, Aruna Lajevardi, Sepehr S Vandervord, Elle Vandervord, John Lang, Thomas C Fulcher, Gregory Jackson, Christopher J Wijewardena, Aruna Lajevardi, Sepehr S Vandervord, Elle Vandervord, John Lang, Thomas C Fulcher, Gregory Jackson, Christopher J |
|---|---|
| author |
Wijewardena, Aruna Lajevardi, Sepehr S Vandervord, Elle Vandervord, John Lang, Thomas C Fulcher, Gregory Jackson, Christopher J |
| spellingShingle |
Wijewardena, Aruna Lajevardi, Sepehr S Vandervord, Elle Vandervord, John Lang, Thomas C Fulcher, Gregory Jackson, Christopher J International Wound Journal Activated protein C to heal pressure ulcers Dermatology Surgery |
| author_sort |
wijewardena, aruna |
| spelling |
Wijewardena, Aruna Lajevardi, Sepehr S Vandervord, Elle Vandervord, John Lang, Thomas C Fulcher, Gregory Jackson, Christopher J 1742-4801 1742-481X Wiley Dermatology Surgery http://dx.doi.org/10.1111/iwj.12343 <jats:title>Abstract</jats:title><jats:p>Pressure ulcers present a major clinical challenge, are physically debilitating and place the patient at risk of serious comorbidities such as septic shock. Recombinant human activated protein C (<jats:styled-content style="fixed-case">APC</jats:styled-content>) is an anticoagulant with anti‐inflammatory, cytoprotective and angiogenic effects that promote rapid wound healing. Topical negative pressure wound therapy (<jats:styled-content style="fixed-case">TNP</jats:styled-content>) has become widely used as a treatment modality in wounds although its efficacy has not been proven through randomised controlled trials. The aim of this study was to determine the preliminary efficacy and safety of treatment with <jats:styled-content style="fixed-case">APC</jats:styled-content> for severe chronic pressure sores with and without <jats:styled-content style="fixed-case">TNP</jats:styled-content>. This case presentation describes the history, management and outcome of two patients each with a severe chronic non‐healing pressure ulcer that had failed to respond to conventional therapy. <jats:styled-content style="fixed-case">TNP</jats:styled-content> was added to conservative management of both ulcers with no improvement seen. Then local application of small doses of <jats:styled-content style="fixed-case">APC</jats:styled-content> was added to <jats:styled-content style="fixed-case">TNP</jats:styled-content> and with conservative management, resulted in significant clinical improvement and rapid healing of both ulcers, displaying rapid growth of vascular granulation tissue with subsequent epithelialisation. Patients tolerated the treatment well and improvements suggested by long‐term follow‐up were provided. Randomised placebo‐controlled double blind trials are needed to quantify the efficacy, safety, cost‐effectiveness, optimal dose and quality of life changes seen from treatment with <jats:styled-content style="fixed-case">APC</jats:styled-content>.</jats:p> Activated protein C to heal pressure ulcers International Wound Journal |
| doi_str_mv |
10.1111/iwj.12343 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9pd2ouMTIzNDM |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9pd2ouMTIzNDM |
| institution |
DE-Pl11 DE-Rs1 DE-14 DE-105 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Zi4 DE-Gla1 DE-15 |
| imprint |
Wiley, 2016 |
| imprint_str_mv |
Wiley, 2016 |
| issn |
1742-4801 1742-481X |
| issn_str_mv |
1742-4801 1742-481X |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
wijewardena2016activatedproteinctohealpressureulcers |
| publishDateSort |
2016 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
International Wound Journal |
| source_id |
49 |
| title |
Activated protein C to heal pressure ulcers |
| title_unstemmed |
Activated protein C to heal pressure ulcers |
| title_full |
Activated protein C to heal pressure ulcers |
| title_fullStr |
Activated protein C to heal pressure ulcers |
| title_full_unstemmed |
Activated protein C to heal pressure ulcers |
| title_short |
Activated protein C to heal pressure ulcers |
| title_sort |
activated protein c to heal pressure ulcers |
| topic |
Dermatology Surgery |
| url |
http://dx.doi.org/10.1111/iwj.12343 |
| publishDate |
2016 |
| physical |
986-991 |
| description |
<jats:title>Abstract</jats:title><jats:p>Pressure ulcers present a major clinical challenge, are physically debilitating and place the patient at risk of serious comorbidities such as septic shock. Recombinant human activated protein C (<jats:styled-content style="fixed-case">APC</jats:styled-content>) is an anticoagulant with anti‐inflammatory, cytoprotective and angiogenic effects that promote rapid wound healing. Topical negative pressure wound therapy (<jats:styled-content style="fixed-case">TNP</jats:styled-content>) has become widely used as a treatment modality in wounds although its efficacy has not been proven through randomised controlled trials. The aim of this study was to determine the preliminary efficacy and safety of treatment with <jats:styled-content style="fixed-case">APC</jats:styled-content> for severe chronic pressure sores with and without <jats:styled-content style="fixed-case">TNP</jats:styled-content>. This case presentation describes the history, management and outcome of two patients each with a severe chronic non‐healing pressure ulcer that had failed to respond to conventional therapy. <jats:styled-content style="fixed-case">TNP</jats:styled-content> was added to conservative management of both ulcers with no improvement seen. Then local application of small doses of <jats:styled-content style="fixed-case">APC</jats:styled-content> was added to <jats:styled-content style="fixed-case">TNP</jats:styled-content> and with conservative management, resulted in significant clinical improvement and rapid healing of both ulcers, displaying rapid growth of vascular granulation tissue with subsequent epithelialisation. Patients tolerated the treatment well and improvements suggested by long‐term follow‐up were provided. Randomised placebo‐controlled double blind trials are needed to quantify the efficacy, safety, cost‐effectiveness, optimal dose and quality of life changes seen from treatment with <jats:styled-content style="fixed-case">APC</jats:styled-content>.</jats:p> |
| container_issue |
5 |
| container_start_page |
986 |
| container_title |
International Wound Journal |
| container_volume |
13 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792344435375210501 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:07:31.476Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Activated+protein+C+to+heal+pressure+ulcers&rft.date=2016-10-01&genre=article&issn=1742-481X&volume=13&issue=5&spage=986&epage=991&pages=986-991&jtitle=International+Wound+Journal&atitle=Activated+protein+C+to+heal+pressure+ulcers&aulast=Jackson&aufirst=Christopher+J&rft_id=info%3Adoi%2F10.1111%2Fiwj.12343&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792344435375210501 |
| author | Wijewardena, Aruna, Lajevardi, Sepehr S, Vandervord, Elle, Vandervord, John, Lang, Thomas C, Fulcher, Gregory, Jackson, Christopher J |
| author_facet | Wijewardena, Aruna, Lajevardi, Sepehr S, Vandervord, Elle, Vandervord, John, Lang, Thomas C, Fulcher, Gregory, Jackson, Christopher J, Wijewardena, Aruna, Lajevardi, Sepehr S, Vandervord, Elle, Vandervord, John, Lang, Thomas C, Fulcher, Gregory, Jackson, Christopher J |
| author_sort | wijewardena, aruna |
| container_issue | 5 |
| container_start_page | 986 |
| container_title | International Wound Journal |
| container_volume | 13 |
| description | <jats:title>Abstract</jats:title><jats:p>Pressure ulcers present a major clinical challenge, are physically debilitating and place the patient at risk of serious comorbidities such as septic shock. Recombinant human activated protein C (<jats:styled-content style="fixed-case">APC</jats:styled-content>) is an anticoagulant with anti‐inflammatory, cytoprotective and angiogenic effects that promote rapid wound healing. Topical negative pressure wound therapy (<jats:styled-content style="fixed-case">TNP</jats:styled-content>) has become widely used as a treatment modality in wounds although its efficacy has not been proven through randomised controlled trials. The aim of this study was to determine the preliminary efficacy and safety of treatment with <jats:styled-content style="fixed-case">APC</jats:styled-content> for severe chronic pressure sores with and without <jats:styled-content style="fixed-case">TNP</jats:styled-content>. This case presentation describes the history, management and outcome of two patients each with a severe chronic non‐healing pressure ulcer that had failed to respond to conventional therapy. <jats:styled-content style="fixed-case">TNP</jats:styled-content> was added to conservative management of both ulcers with no improvement seen. Then local application of small doses of <jats:styled-content style="fixed-case">APC</jats:styled-content> was added to <jats:styled-content style="fixed-case">TNP</jats:styled-content> and with conservative management, resulted in significant clinical improvement and rapid healing of both ulcers, displaying rapid growth of vascular granulation tissue with subsequent epithelialisation. Patients tolerated the treatment well and improvements suggested by long‐term follow‐up were provided. Randomised placebo‐controlled double blind trials are needed to quantify the efficacy, safety, cost‐effectiveness, optimal dose and quality of life changes seen from treatment with <jats:styled-content style="fixed-case">APC</jats:styled-content>.</jats:p> |
| doi_str_mv | 10.1111/iwj.12343 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9pd2ouMTIzNDM |
| imprint | Wiley, 2016 |
| imprint_str_mv | Wiley, 2016 |
| institution | DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Zi4, DE-Gla1, DE-15 |
| issn | 1742-4801, 1742-481X |
| issn_str_mv | 1742-4801, 1742-481X |
| language | English |
| last_indexed | 2024-03-01T17:07:31.476Z |
| match_str | wijewardena2016activatedproteinctohealpressureulcers |
| mega_collection | Wiley (CrossRef) |
| physical | 986-991 |
| publishDate | 2016 |
| publishDateSort | 2016 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | International Wound Journal |
| source_id | 49 |
| spelling | Wijewardena, Aruna Lajevardi, Sepehr S Vandervord, Elle Vandervord, John Lang, Thomas C Fulcher, Gregory Jackson, Christopher J 1742-4801 1742-481X Wiley Dermatology Surgery http://dx.doi.org/10.1111/iwj.12343 <jats:title>Abstract</jats:title><jats:p>Pressure ulcers present a major clinical challenge, are physically debilitating and place the patient at risk of serious comorbidities such as septic shock. Recombinant human activated protein C (<jats:styled-content style="fixed-case">APC</jats:styled-content>) is an anticoagulant with anti‐inflammatory, cytoprotective and angiogenic effects that promote rapid wound healing. Topical negative pressure wound therapy (<jats:styled-content style="fixed-case">TNP</jats:styled-content>) has become widely used as a treatment modality in wounds although its efficacy has not been proven through randomised controlled trials. The aim of this study was to determine the preliminary efficacy and safety of treatment with <jats:styled-content style="fixed-case">APC</jats:styled-content> for severe chronic pressure sores with and without <jats:styled-content style="fixed-case">TNP</jats:styled-content>. This case presentation describes the history, management and outcome of two patients each with a severe chronic non‐healing pressure ulcer that had failed to respond to conventional therapy. <jats:styled-content style="fixed-case">TNP</jats:styled-content> was added to conservative management of both ulcers with no improvement seen. Then local application of small doses of <jats:styled-content style="fixed-case">APC</jats:styled-content> was added to <jats:styled-content style="fixed-case">TNP</jats:styled-content> and with conservative management, resulted in significant clinical improvement and rapid healing of both ulcers, displaying rapid growth of vascular granulation tissue with subsequent epithelialisation. Patients tolerated the treatment well and improvements suggested by long‐term follow‐up were provided. Randomised placebo‐controlled double blind trials are needed to quantify the efficacy, safety, cost‐effectiveness, optimal dose and quality of life changes seen from treatment with <jats:styled-content style="fixed-case">APC</jats:styled-content>.</jats:p> Activated protein C to heal pressure ulcers International Wound Journal |
| spellingShingle | Wijewardena, Aruna, Lajevardi, Sepehr S, Vandervord, Elle, Vandervord, John, Lang, Thomas C, Fulcher, Gregory, Jackson, Christopher J, International Wound Journal, Activated protein C to heal pressure ulcers, Dermatology, Surgery |
| title | Activated protein C to heal pressure ulcers |
| title_full | Activated protein C to heal pressure ulcers |
| title_fullStr | Activated protein C to heal pressure ulcers |
| title_full_unstemmed | Activated protein C to heal pressure ulcers |
| title_short | Activated protein C to heal pressure ulcers |
| title_sort | activated protein c to heal pressure ulcers |
| title_unstemmed | Activated protein C to heal pressure ulcers |
| topic | Dermatology, Surgery |
| url | http://dx.doi.org/10.1111/iwj.12343 |